Acalabrutinib Demonstrates Improved Safety, Survival to Chemoimmunotherapy in CLL
Acalabrutinib shows improved safety and survival rates in chronic lymphocytic leukemia (CLL), reducing risks of mortality and cardiovascular complications.
Acetaminophen
This is a consumer webpage focused on the safe use of over-the-counter acetaminophen-containing products.
BEAM-101 Receives RMAT for the Treatment of Sickle Cell Disease
The designation is supported by promising results from the ongoing phase 1/2 BEACON clinical trial.
Pharmacists’ Knowledge Gaps on Kratom: Building Competence for Patient Counseling
Pharmacists explore kratom’s potential benefits and risks, emphasizing the need for education on its effects, safety, and patient guidance.
Tyson adjusts beef production in face of low supply, healthy demand
The meat processor has cut costs from its operation and slowed processing speeds to get the most from record-low cattle…
GE Appliances to invest $3B in US manufacturing
The funds will help the front-load washer manufacturer continue to reshore production from Mexico and China. The company’s first phase…
Patient Perceptions Support Co-Management of Chronic Kidney Disease
A collaborative care model enhances education and management for patients with chronic kidney disease, improving outcomes and understanding.
The Center for Research on Complex Generics
FDA awards a 5-year grant to the University of Maryland and the University of Michigan to establish a Center for…